Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 40% ± 15% | |
glutamatergic neuron | 13 studies | 47% ± 21% | |
oligodendrocyte precursor cell | 11 studies | 29% ± 12% | |
GABAergic neuron | 10 studies | 46% ± 21% | |
neuron | 9 studies | 46% ± 19% | |
astrocyte | 8 studies | 24% ± 7% | |
amacrine cell | 8 studies | 41% ± 19% | |
interneuron | 7 studies | 46% ± 24% | |
retinal ganglion cell | 7 studies | 62% ± 26% | |
granule cell | 4 studies | 37% ± 14% | |
GABAergic amacrine cell | 4 studies | 31% ± 16% | |
endothelial cell | 3 studies | 39% ± 11% | |
GABAergic interneuron | 3 studies | 45% ± 7% | |
glycinergic amacrine cell | 3 studies | 31% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 41% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 13191.87 | 2642 / 2642 | 99% | 65.64 | 699 / 705 |
adrenal gland | 1% | 28.62 | 3 / 258 | 60% | 19.43 | 138 / 230 |
ovary | 0% | 0 | 0 / 180 | 6% | 0.42 | 25 / 430 |
uterus | 0% | 0 | 0 / 170 | 4% | 0.57 | 18 / 459 |
skin | 0% | 0 | 0 / 1809 | 3% | 0.16 | 12 / 472 |
eye | 0% | 0 | 0 / 0 | 3% | 0.31 | 2 / 80 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.66 | 4 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
breast | 0% | 0 | 0 / 459 | 2% | 0.37 | 24 / 1118 |
thymus | 0% | 0 | 0 / 653 | 2% | 0.23 | 10 / 605 |
lung | 0% | 0 | 0 / 578 | 1% | 0.19 | 17 / 1155 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.08 | 6 / 502 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.90 | 6 / 504 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.08 | 10 / 901 |
esophagus | 0% | 0 | 0 / 1445 | 1% | 0.08 | 2 / 183 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.16 | 2 / 286 |
intestine | 0% | 0.88 | 1 / 966 | 0% | 0.01 | 1 / 527 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030154 | Biological process | cell differentiation |
GO_0007399 | Biological process | nervous system development |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005515 | Molecular function | protein binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
Gene name | ELAVL3 |
Protein name | ELAVL3 protein ELAV like RNA binding protein 3 ELAV-like protein ELAV-like protein 3 (Hu-antigen C) (HuC) (Paraneoplastic cerebellar degeneration-associated antigen) (Paraneoplastic limbic encephalitis antigen 21) Alternative protein ELAVL3 |
Synonyms | PLE21 DKFZp547J036 HUC |
Description | FUNCTION: RNA-binding protein that binds to AU-rich element (ARE) sequences of target mRNAs, including VEGF mRNA . May also bind poly-A tracts via RRM 3 (By similarity). May be involved in neuronal differentiation and maintenance (By similarity). Plays a role in the stabilization of GAP43 mRNA and in spatial learning (By similarity). . |
Accessions | Q9H024 ENST00000359227.8 [Q14576-1] ENST00000438662.6 [Q14576-2] Q14576 Q96J71 L8E8Z0 ENST00000588853.1 K7EPB5 |